Monopar Therapeutics SEC filings MNPR

Monopar Therapeutics has 536 filings in SEC EDGAR's recent list, going back to Jun 18, 2015. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 12, 2026 (results of operations). The company's fiscal year ends on December 31.

Monopar Therapeutics SEC filings
Form Description Filed Period
8-K Current report
Results of operations
Aug 12, 2026 Aug 12, 2026
10-Q Quarterly report Aug 12, 2026 Jun 30, 2026
S-8 POS Form s-8 pos Jul 22, 2026 —
S-8 POS Form s-8 pos Jul 22, 2026 —
S-8 POS Form s-8 pos Jul 22, 2026 —
S-8 POS Form s-8 pos Jul 22, 2026 —
S-8 Employee stock plan registration Jul 22, 2026 —
8-K Current report
Regulation FD disclosure
Jul 22, 2026 Jul 22, 2026
8-K Current report
Regulation FD disclosure
Jun 30, 2026 Jun 30, 2026
8-K Current report
Regulation FD disclosure
Jun 26, 2026 Jun 26, 2026
8-K Current report
Shareholder vote results
Jun 23, 2026 Jun 22, 2026
8-K Current report
Regulation FD disclosure
May 29, 2026 May 29, 2026
8-K Current report
Regulation FD disclosure
May 19, 2026 May 19, 2026
10-Q Quarterly report May 14, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 14, 2026 May 14, 2026
ARS Annual report to shareholders Apr 30, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 30, 2026 —
DEF 14A Proxy statement Apr 30, 2026 Jun 22, 2026
8-K Current report
Regulation FD disclosure
Apr 20, 2026 Apr 19, 2026
10-K/A Amended annual report Apr 1, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 27, 2026 Mar 27, 2026
10-K Annual report Mar 27, 2026 Dec 31, 2025
8-K Current report
Regulation FD disclosure
Mar 2, 2026 Mar 2, 2026
8-K Current report
Results of operations
Nov 13, 2025 Nov 13, 2025
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Regulation FD disclosure
Nov 10, 2025 Nov 9, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Sep 24, 2025 Sep 23, 2025
424B5 Prospectus supplement Sep 24, 2025 —
8-K Current report
Regulation FD disclosure
Sep 15, 2025 Sep 15, 2025
EFFECT Filing Sep 9, 2025 —
CORRESP Letter to the SEC Sep 5, 2025 —
UPLOAD Letter from the SEC Sep 4, 2025 —
S-3 Shelf registration Aug 29, 2025 —
8-K Current report
Results of operations
Aug 12, 2025 Aug 12, 2025
10-Q Quarterly report Aug 12, 2025 Jun 30, 2025
UPLOAD Letter from the SEC Jul 25, 2025 —
CORRESP Letter to the SEC Jul 22, 2025 —
UPLOAD Letter from the SEC Jul 16, 2025 —
8-K Current report
Shareholder vote results
Jun 23, 2025 Jun 17, 2025
DEFA14A Additional proxy material May 23, 2025 —
10-Q Quarterly report May 13, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 13, 2025 May 13, 2025
ARS Annual report to shareholders May 12, 2025 Dec 31, 2024
8-K Current report
Regulation FD disclosure
May 7, 2025 May 7, 2025
DEF 14A Proxy statement Apr 30, 2025 Jun 17, 2025
8-K Current report
Results of operations
Mar 31, 2025 Mar 31, 2025
S-8 Employee stock plan registration Mar 31, 2025 —
10-K Annual report Mar 31, 2025 Dec 31, 2024
8-K Current report
Officer or director change
Mar 3, 2025 Feb 27, 2025
8-K Current report
Officer or director change
Feb 24, 2025 Feb 19, 2025
EFFECT Filing Jan 27, 2025 —
424B3 Prospectus Jan 27, 2025 —
CORRESP Letter to the SEC Jan 23, 2025 —
UPLOAD Letter from the SEC Jan 22, 2025 —
S-3 Shelf registration Jan 15, 2025 —
8-K Current report
Material agreement, Unregistered share sale
Dec 23, 2024 Dec 20, 2024
424B5 Prospectus supplement Dec 23, 2024 —
424B3 Prospectus Dec 18, 2024 —
EFFECT Filing Dec 17, 2024 —
8-K Current report
Regulation FD disclosure
Dec 6, 2024 Dec 6, 2024
S-3 Shelf registration Nov 29, 2024 —
8-K Current report
Results of operations
Nov 8, 2024 Nov 8, 2024
10-Q Quarterly report Nov 8, 2024 Sep 30, 2024
8-K Current report
Material agreement, Regulation FD disclosure
Oct 30, 2024 Oct 28, 2024
424B5 Prospectus supplement Oct 29, 2024 —
424B5 Prospectus supplement Oct 28, 2024 —
8-K Current report
Material agreement, Acquisition or sale of assets, New debt, Unregistered share sale, Regulation FD disclosure, Other events
Oct 24, 2024 Oct 23, 2024
8-K Current report
Regulation FD disclosure
Oct 22, 2024 Oct 22, 2024
8-K Current report
Regulation FD disclosure
Oct 15, 2024 Oct 15, 2024
8-K Current report
Regulation FD disclosure
Oct 7, 2024 Oct 7, 2024
8-K Current report
Regulation FD disclosure
Sep 12, 2024 Sep 12, 2024
8-K Current report
Regulation FD disclosure
Aug 27, 2024 Aug 27, 2024
8-K Current report
Regulation FD disclosure
Aug 21, 2024 Aug 21, 2024
8-K Current report
Regulation FD disclosure
Aug 14, 2024 Aug 14, 2024
10-Q Quarterly report Aug 9, 2024 Jun 30, 2024
8-K Current report
Results of operations, Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
Aug 9, 2024 Aug 9, 2024
ARS Annual report to shareholders Jul 22, 2024 Dec 31, 2023
DEF 14A Proxy statement Jul 22, 2024 Aug 5, 2024
PRE 14A Preliminary proxy statement Jul 11, 2024 Aug 5, 2024
8-K Current report
Regulation FD disclosure
Jul 9, 2024 Jul 9, 2024
8-K Current report
Regulation FD disclosure
Jun 11, 2024 Jun 11, 2024
8-K Current report
Regulation FD disclosure
Jun 10, 2024 Jun 10, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
May 24, 2024 May 23, 2024
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
8-K Current report
Regulation FD disclosure
Apr 16, 2024 Apr 16, 2024
8-K Current report
Regulation FD disclosure
Apr 10, 2024 Apr 10, 2024
10-K Annual report Mar 28, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 28, 2024 Mar 28, 2024
8-K Current report
Regulation FD disclosure
Mar 7, 2024 Mar 7, 2024
8-K Current report
Regulation FD disclosure
Mar 5, 2024 Mar 5, 2024
8-K Current report
Listing notice
Feb 28, 2024 Feb 27, 2024
8-K Current report
Regulation FD disclosure
Feb 27, 2024 Feb 27, 2024
8-K Current report
Regulation FD disclosure
Feb 22, 2024 Feb 22, 2024
8-K Current report
Regulation FD disclosure
Feb 20, 2024 Feb 20, 2024
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 9, 2023 Nov 9, 2023
8-K Current report
Regulation FD disclosure
Nov 1, 2023 Nov 1, 2023
8-K Current report
Listing notice
Aug 30, 2023 Aug 28, 2023
8-K Current report
Results of operations
Aug 10, 2023 Aug 10, 2023
10-Q Quarterly report Aug 10, 2023 Jun 30, 2023
8-K Current report
Regulation FD disclosure
Aug 8, 2023 Aug 8, 2023
8-K Current report
Regulation FD disclosure
Jul 11, 2023 Jul 11, 2023
8-K Current report
Shareholder vote results
Jun 28, 2023 Jun 27, 2023
8-K Current report
Regulation FD disclosure
Jun 1, 2023 Jun 1, 2023
8-K Current report
Results of operations
May 11, 2023 May 11, 2023
10-Q Quarterly report May 11, 2023 Mar 31, 2023
ARS Annual report to shareholders Apr 28, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 28, 2023 —
DEF 14A Proxy statement Apr 28, 2023 Jun 27, 2023
8-K Current report
Regulation FD disclosure, Other events
Mar 27, 2023 Mar 27, 2023
10-K Annual report Mar 23, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 23, 2023 Mar 23, 2023
8-K Current report
Regulation FD disclosure
Feb 27, 2023 Feb 27, 2023
8-K Current report
Regulation FD disclosure
Feb 14, 2023 Feb 14, 2023
8-K Current report
Regulation FD disclosure
Jan 26, 2023 Jan 26, 2023
8-K Current report
Regulation FD disclosure
Jan 18, 2023 Jan 18, 2023
EFFECT Filing Jan 4, 2023 —
424B5 Prospectus supplement Jan 4, 2023 —
CORRESP Letter to the SEC Dec 29, 2022 —
UPLOAD Letter from the SEC Dec 28, 2022 —
S-3 Shelf registration Dec 21, 2022 —
8-K Current report
Regulation FD disclosure
Dec 12, 2022 Dec 12, 2022
8-K Current report
Regulation FD disclosure
Nov 16, 2022 Nov 16, 2022
10-Q Quarterly report Nov 10, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 10, 2022 Nov 10, 2022
8-K Current report
Regulation FD disclosure
Oct 5, 2022 Oct 5, 2022
S-8 Employee stock plan registration Aug 12, 2022 —
10-Q Quarterly report Aug 11, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 11, 2022 Aug 11, 2022
8-K Current report
Officer or director change, Shareholder vote results
Jun 30, 2022 Jun 28, 2022
8-K Current report
Results of operations
May 12, 2022 May 12, 2022
10-Q Quarterly report May 12, 2022 Mar 31, 2022
DEFA14A Additional proxy material Apr 29, 2022 —
DEF 14A Proxy statement Apr 29, 2022 Jun 28, 2022
8-K Current report
Material agreement
Apr 20, 2022 Apr 20, 2022
424B5 Prospectus supplement Apr 20, 2022 —
8-K Current report
Officer or director change
Apr 1, 2022 Mar 28, 2022
10-K Annual report Mar 24, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 24, 2022 Mar 24, 2022
8-K Current report
Regulation FD disclosure
Feb 15, 2022 Feb 15, 2022
8-K Current report
Regulation FD disclosure
Dec 8, 2021 Dec 8, 2021
8-K Current report
Results of operations
Nov 12, 2021 Nov 12, 2021
10-Q Quarterly report Nov 12, 2021 Sep 30, 2021
8-K Current report
Regulation FD disclosure
Oct 27, 2021 Oct 27, 2021
8-K Current report
Regulation FD disclosure
Sep 16, 2021 Sep 16, 2021
8-K Current report
Regulation FD disclosure
Sep 13, 2021 Sep 13, 2021
10-Q Quarterly report Aug 12, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 12, 2021 Aug 12, 2021
8-K Current report
Regulation FD disclosure
Aug 5, 2021 Aug 5, 2021
8-K Current report
Regulation FD disclosure
Aug 3, 2021 Aug 3, 2021
8-K Current report
Regulation FD disclosure
Jul 12, 2021 Jul 12, 2021
8-K Current report
Officer or director change, Shareholder vote results
Jul 2, 2021 Jun 30, 2021
8-K Current report
Regulation FD disclosure
Jun 24, 2021 Jun 24, 2021
8-K Current report
Regulation FD disclosure
Jun 3, 2021 Jun 3, 2021
8-K Current report
Officer or director change
Jun 1, 2021 Jun 1, 2021
8-K Current report
Regulation FD disclosure
Jun 1, 2021 Jun 1, 2021
8-K Current report
Regulation FD disclosure
May 26, 2021 May 26, 2021
8-K Current report
Regulation FD disclosure
May 24, 2021 May 24, 2021
10-Q Quarterly report May 13, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 13, 2021 Mar 31, 2021
DEFA14A Additional proxy material May 3, 2021 —
DEF 14A Proxy statement Apr 30, 2021 Jun 30, 2021
8-K Current report
Regulation FD disclosure
Mar 30, 2021 Mar 30, 2021
8-K Current report
Results of operations
Mar 25, 2021 Mar 25, 2021
10-K Annual report Mar 25, 2021 Dec 31, 2020
8-K Current report
Regulation FD disclosure
Feb 16, 2021 Feb 1, 2021
8-K Current report
Regulation FD disclosure
Feb 11, 2021 Feb 11, 2021
8-K Current report
Regulation FD disclosure
Feb 9, 2021 Feb 9, 2021
8-K Current report
Regulation FD disclosure
Dec 22, 2020 Dec 22, 2020
8-K Current report
Regulation FD disclosure
Dec 10, 2020 Dec 10, 2020
8-K Current report
Regulation FD disclosure
Dec 8, 2020 Dec 8, 2020
S-8 Employee stock plan registration Nov 13, 2020 —
10-Q Quarterly report Nov 12, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 12, 2020 Sep 30, 2020
8-K Current report
Regulation FD disclosure
Nov 9, 2020 Nov 9, 2020
8-K Current report
Regulation FD disclosure
Sep 9, 2020 Sep 9, 2020
8-K Current report
Regulation FD disclosure
Aug 19, 2020 Aug 17, 2020
8-K Current report
Regulation FD disclosure
Aug 12, 2020 Aug 12, 2020
8-K Current report
Regulation FD disclosure, Other events
Aug 10, 2020 Aug 10, 2020
10-Q Quarterly report Aug 6, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 6, 2020 Aug 6, 2020
8-K Current report
Regulation FD disclosure
Jun 30, 2020 Jun 30, 2020
8-K Current report
Regulation FD disclosure, Other events
Jun 16, 2020 Jun 16, 2020
8-K Current report
Officer or director change, Shareholder vote results
Jun 15, 2020 Jun 11, 2020
8-K Current report
Results of operations
May 7, 2020 Mar 31, 2020
10-Q Quarterly report May 7, 2020 Mar 31, 2020
DEFA14A Additional proxy material Apr 29, 2020 —
DEF 14A Proxy statement Apr 29, 2020 Jun 11, 2020
10-K Annual report Mar 27, 2020 Dec 31, 2019
8-K Current report
Results of operations
Mar 27, 2020 Dec 31, 2019
8-K Current report
Regulation FD disclosure
Feb 18, 2020 Feb 18, 2020
EFFECT Filing Jan 13, 2020 —
8-K Current report
Material agreement
Jan 13, 2020 Jan 13, 2020
424B5 Prospectus supplement Jan 13, 2020 —
CORRESP Letter to the SEC Jan 10, 2020 —
UPLOAD Letter from the SEC Jan 10, 2020 —
8-K Current report Jan 7, 2020 Jan 7, 2020
S-3 Shelf registration Jan 3, 2020 —
S-8 Employee stock plan registration Jan 3, 2020 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
MNPR (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Wilmette, IL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1645469

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.